Combination treatment improves response to immunotherapy for lung cancer

Triplet regimen yields promising response in advanced-phase chronic myeloid leukemia

Long-term metastatic melanoma survival dramatically improves on immunotherapy, study finds

Immunotherapy shows promise for men with specific types of prostate cancer